UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

Gastroenterology (New York, N.Y. 1943), 1999-11, Vol.117 (5), p.1187-1197

1999

Volltextzugriff (PDF)

Expression of the Terminal Protein Region of Hepatitis B Virus Inhibits Cellular Responses to Interferons α and γ and Double-Stranded RNA

Proceedings of the National Academy of Sciences - PNAS, 1991-04, Vol.88 (7), p.2888-2892

1991

Volltextzugriff (PDF)

Expression and characterization of the hepatitis G virus helicase

Journal of viral hepatitis, 1998-01, Vol.5 (1), p.21-26

1998

Volltextzugriff (PDF)

Regulation of major histocompatibility class I gene expression at the level of transcription in highly oncogenic adenovirus transformed rat cells

Oncogene, 1988-10, Vol.3 (4), p.483-487

1988

Volltextzugriff (PDF)

Nuclear proteins binding to an enhancer element of the major histocompatibility class I promoter: Differences between highly oncogenic and nononcogenic adenovirus-transformed rat cells

Virology (New York, N.Y.), 1989-10, Vol.172 (2), p.643-646

1989

Volltextzugriff (PDF)

Specific deletions in the hepatitis B virus core open reading frame in patients with chronic active hepatitis B

Journal of medical virology, 1993-10, Vol.41 (2), p.165-169

1993

Volltextzugriff (PDF)

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

Hepatology (Baltimore, Md.), 2006-05, Vol.43 (5), p.954-960

2006

Volltextzugriff (PDF)

Selection of HCV NS5A quasispecies during IFN therapy in patients with chronic HCV

Digestive diseases and sciences, 2001-07, Vol.46 (7), p.1399-1408

2001

Volltextzugriff (PDF)

Interferon-γ regulation of major histocompatibility class I gene expression in rat cells containing the adenovirus 12 E1A oncogene

Virology (New York, N.Y.), 1990, Vol.174 (1), p.325-328

1990

Volltextzugriff (PDF)

Transcription factors induced by interferons α and γ

Nucleic acids research, 1990-11, Vol.18 (22), p.6573-6580

1990

Volltextzugriff (PDF)

Differential response of the human 6-16 and 9-27 genes to α and γ interferons

Nucleic acids research, 1991-02, Vol.19 (3), p.591-598

1991

Volltextzugriff (PDF)

Comparison of pre-core/core hepatitis B virus region in liver tissue and serum from patients with chronic hepatitis B infection

Journal of hepatology, 1992, Vol.16 (1), p.224-227

1992

Volltextzugriff (PDF)

Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin

Annals of internal medicine, 2004-01, Vol.140 (1), p.72

2004

Volltextzugriff (PDF)

Expression of hamster MHC class I antigens in transformed cells and tumours induced by human adenoviruses

European journal of cancer & clinical oncology, 1988-11, Vol.24 (11), p.1745-1750

1988

Volltextzugriff (PDF)

Modulation of expression of major histocompatibility class I genes in highly oncogenic adenovirus-transformed rat cells

Biochemical Society transactions, 1988-08, Vol.16 (4), p.605-606

1988

Volltextzugriff (PDF)

Inhibition of the cellular response to interferon by products of the adenovirus type 5 E1A oncogene

Nucleic acids research, 1991, Vol.19 (16), p.4387-4393

1991

Volltextzugriff (PDF)

Expression of the terminal protein region of hepatitis B virus inhibits cellular response to interferons alpha and gamma and double-stranded RNA

Proceedings of the National Academy of Sciences - PNAS, 1991-01, Vol.88 (7), p.2888-2892

1991

Volltextzugriff (PDF)

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy

Hepatology (Baltimore, Md.), 2006-05, Vol.43 (5), p.954-960

2006

Volltextzugriff (PDF)

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose

Annals of internal medicine, 2004-03, Vol.140 (5), p.346

Hadziyannis, Stephanos J.

2004

Volltextzugriff (PDF)

Sugar trade and the role of historical colonial linkages

European review of agricultural economics, 2019-02, Vol.46 (1), p.79-108

2019

Volltextzugriff (PDF)

Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis

JHEP reports, 2019-10, Vol.1 (4), p.286-296

2019

Volltextzugriff (PDF)

P23 Target And Biomarker Discovery For Hedgehog Pathway Activity In Idiopathic Pulmonary Fibrosis In Support Of A Phase 2 Randomised, Double-blind, Placebo-controlled Study To Assess Efficacy And Safety Of Vismodegib In Ipf (island)

Thorax, 2014-12, Vol.69 (Suppl 2), p.A87-A87

2014

Volltextzugriff (PDF)

Optimized Virologic Response in Hepatitis C Virus Genotype 4 with Peginterferon-α2a and Ribavirin

Annals of internal medicine, 2004-01, Vol.140 (1), p.72

2004

Volltextzugriff (PDF)

Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: Further evidence implicating calcium homeostasis in blood pressure regulation

American journal of kidney diseases, 1996-06, Vol.27 (6), p.819-825

1996

Volltextzugriff (PDF)

Ambulatory blood pressure monitoring in renal dialysis and transplant patients

American journal of kidney diseases, 1997-04, Vol.29 (4), p.593-600

1997

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(124)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

Expression of the Terminal Protein Region of Hepatitis B Virus Inhibits Cellular Responses to Interferons α and γ and Double-Stranded RNA

Expression and characterization of the hepatitis G virus helicase

Regulation of major histocompatibility class I gene expression at the level of transcription in highly oncogenic adenovirus transformed rat cells

Nuclear proteins binding to an enhancer element of the major histocompatibility class I promoter: Differences between highly oncogenic and nononcogenic adenovirus-transformed rat cells

Specific deletions in the hepatitis B virus core open reading frame in patients with chronic active hepatitis B

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

Selection of HCV NS5A quasispecies during IFN therapy in patients with chronic HCV

Interferon-γ regulation of major histocompatibility class I gene expression in rat cells containing the adenovirus 12 E1A oncogene

Transcription factors induced by interferons α and γ

Differential response of the human 6-16 and 9-27 genes to α and γ interferons

Comparison of pre-core/core hepatitis B virus region in liver tissue and serum from patients with chronic hepatitis B infection

Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin

Expression of hamster MHC class I antigens in transformed cells and tumours induced by human adenoviruses

Modulation of expression of major histocompatibility class I genes in highly oncogenic adenovirus-transformed rat cells

Inhibition of the cellular response to interferon by products of the adenovirus type 5 E1A oncogene

Expression of the terminal protein region of hepatitis B virus inhibits cellular response to interferons alpha and gamma and double-stranded RNA

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose

Sugar trade and the role of historical colonial linkages

Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis

P23 Target And Biomarker Discovery For Hedgehog Pathway Activity In Idiopathic Pulmonary Fibrosis In Support Of A Phase 2 Randomised, Double-blind, Placebo-controlled Study To Assess Efficacy And Safety Of Vismodegib In Ipf (island)

Optimized Virologic Response in Hepatitis C Virus Genotype 4 with Peginterferon-α2a and Ribavirin

Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: Further evidence implicating calcium homeostasis in blood pressure regulation

Ambulatory blood pressure monitoring in renal dialysis and transplant patients

Suchergebnisse filtern